Skip to main content
Top
Metadata
Title
Response to Nardone
Authors
Kaitlin Strauss
Charles MacLean, MDCM
Austin Troy, PhD
Benjamin Littenberg, MD
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 9/2006
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/BF02743159

Other articles of this Issue 9/2006

Journal of General Internal Medicine 9/2006 Go to the issue

Original Articles

Creating enduring change

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine